Study to evaluate â??AyurCoro3 ( Ayurvedic Preparation )â?? in covid-19 treatment.
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/05/033301
- Lead Sponsor
- Shri Sarveshwar Seva Sahkari Samstha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Laboratory confirmed diagnosis of Mild to Moderate COVID-19 patients
2.Patients in whom Ayurcoro-3 (as a adjuvant to the standard of care for mild to moderate covid-19) is prescribed by treating doctor.
3.All Age groups above 18 Years
4.All genders.
Exclusion Criteria
1.Patients on ventilator
2.Critically ill patient
3.Severe covid-19 patients (Dyspnea, respiratory frequency >= 30/min, Blood oxygen saturation (SpO2) <= 90%, PaO2/FiO2 ratio < 300, and/or lung infiltrates > 50% within 24 to 48 hours)
4.Patients not willing to consent for the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time (Days) to clinical improvementTimepoint: At Discharge
- Secondary Outcome Measures
Name Time Method 1.Clinical status as assessed by the 8-point ordinal scale <br/ ><br>2.Duration of hospitalization (At discharge) <br/ ><br>3.Proportion of participants in each group with need for mechanical ventilation (At discharge) <br/ ><br>4.Rate of patients showing improvement of 2 points in 7 category ordinal scale <br/ ><br>5.Functional status scale -post covid-19 at 1 week post discharge Follow up visit. <br/ ><br>Timepoint: At Day-3 , Day-5 Day-7 , Discharge and 1 Week post discharge